跳至主要内容
临床试验/NCT05409846
NCT05409846已完成不适用

Frequency of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies

Universidade do Porto11 个研究点 分布在 1 个国家目标入组 409 人开始时间: 2022年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
409
试验地点
11
主要终点
Frequency of Fabry Disease in patients with idiopathic cardiomyopathies

研究概览

简要总结

In Portugal, the prevalence of Fabry disease is largely unknown as recently has been stressed by the Portuguese hypertrophic cardiomyopathy registry investigators.

On the other hand, few data on Fabry screening protocols in patients with compromised ejection fraction including burned-out hypertrophic cardiomyopathy series have been published.

This project intends to perform screening of Fabry disease in patients with distinct cardiomyopathy phenotypes of unknown or dubious etiology and explore the less knew impact of the disease in other cardiac phenotypes.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with heart disease diagnosed after the age of 30:
  • unexplained hypertrophic cardiomyopathy (Group A)
  • unexplained left ventricle hypertrophy confirmed in two different examinations using the same or different imaging methods (Group B)
  • unexplained burned-out hypertrophic cardiomyopathy (Group C)
  • unexplained dilated cardiomyopathy with evidence of late gadolinium enhancement involving the basal posterolateral wall segments (Group D)

排除标准

  • previous exclusion of Fabry disease
  • previous identified causal pathogenic/likely pathogenic genetic variant
  • evidence of cardiomyopathy under the age of 30

结局指标

主要结局

Frequency of Fabry Disease in patients with idiopathic cardiomyopathies

时间窗: 12 months

Ratio of number of patients with Fabry Disease and total number of idiopathic cardiomyopathies patients

次要结局

  • Familiar screening of Fabry Disease(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (11)

Loading locations...

相似试验

Screening of Fabry Disease in Portuguese Patients... | 临床试验